Clinical-stage biotechnology company developing cancer therapies.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Based on 1 scored insight about Erasca, Inc..
The 1 sources with the most insights about Erasca, Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Mentioned among biotech fund holdings; no company-specific investment analysis was provided.
Mentioned among biotech fund holdings; no company-specific investment analysis was provided.
Other assets that creators frequently mention in the same content as Erasca, Inc..
The most active sources covering Erasca, Inc. (ERAS) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about Erasca, Inc. (ERAS) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Erasca, Inc. (ERAS) most frequently also discuss BHVN, SFTBY, LEGN, CGON, ACAD. See the "Discussed alongside" section above for full asset pages.